Vandetanib
Vandetanib (INN, trade name Caprelsa) is an anti-cancer drug that is used for the treatment of certain tumours of the thyroid gland. It acts as a kinase inhibitor of a number of cell receptors, mainly the vascular endothelial growth factor receptor (VEGFR), the epidermal growth factor receptor (EGFR), and the RET-tyrosine kinase. The drug was developed by AstraZeneca.
Wikipage redirect
differentFrom
primaryTopic
Vandetanib
Vandetanib (INN, trade name Caprelsa) is an anti-cancer drug that is used for the treatment of certain tumours of the thyroid gland. It acts as a kinase inhibitor of a number of cell receptors, mainly the vascular endothelial growth factor receptor (VEGFR), the epidermal growth factor receptor (EGFR), and the RET-tyrosine kinase. The drug was developed by AstraZeneca.
has abstract
Vandetanib (INN, trade name Ca ...... was developed by AstraZeneca.
@en
バンデタニブ(Vandetanib、商品名:カプレルサ、開発 ...... 長因子受容体(EGFR)、RETチロシンキナーゼを阻害する。
@ja
ATC prefix
ATC suffix
CAS number
443913-73-3
ChEBI
DrugBank
FDA UNII code
YO460OQ37K
IUPAC name
N-(4-bromo-2-fluorophenyl)-6-m ...... -yl)methoxy]quinazolin-4-amine
@en
PubChem
thumbnail
Link from a Wikipage to an external page
Wikipage page ID
Wikipage revision ID
722,777,497
ChEMBL
ChemSpiderID
elimination half-life
1641600.0
excretion
IUPHAR ligand
legal CA
legal US
licence US
MedlinePlus
molecular weight
4.75354e+2
protein bound
routes of administration
smiles
CN1CCCCOc2cc3ccNc4cccBr
StdInChIKey
UHTHHESEBZOYNR-UHFFFAOYSA-N
synonyms
tradename
Verifiedfields
verifiedrevid
470,628,961
subject
hypernym
comment
Vandetanib (INN, trade name Ca ...... was developed by AstraZeneca.
@en
バンデタニブ(Vandetanib、商品名:カプレルサ、開発 ...... 長因子受容体(EGFR)、RETチロシンキナーゼを阻害する。
@ja
label
Vandetanib
@en
バンデタニブ
@ja